JPWO2019206798A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019206798A5
JPWO2019206798A5 JP2020556943A JP2020556943A JPWO2019206798A5 JP WO2019206798 A5 JPWO2019206798 A5 JP WO2019206798A5 JP 2020556943 A JP2020556943 A JP 2020556943A JP 2020556943 A JP2020556943 A JP 2020556943A JP WO2019206798 A5 JPWO2019206798 A5 JP WO2019206798A5
Authority
JP
Japan
Prior art keywords
formula
compound
dihydro
oxo
cyclopropyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020556943A
Other languages
English (en)
Japanese (ja)
Other versions
JP7410050B2 (ja
JP2021521238A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/060072 external-priority patent/WO2019206798A1/fr
Publication of JP2021521238A publication Critical patent/JP2021521238A/ja
Publication of JPWO2019206798A5 publication Critical patent/JPWO2019206798A5/ja
Application granted granted Critical
Publication of JP7410050B2 publication Critical patent/JP7410050B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020556943A 2018-04-25 2019-04-18 キノロンカルボン酸エステルの加水分解プロセス Active JP7410050B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18169170 2018-04-25
EP18169170.0 2018-04-25
PCT/EP2019/060072 WO2019206798A1 (fr) 2018-04-25 2019-04-18 Procédé d'hydrolyse d'esters d'acides quinolone-carboxyliques

Publications (3)

Publication Number Publication Date
JP2021521238A JP2021521238A (ja) 2021-08-26
JPWO2019206798A5 true JPWO2019206798A5 (fr) 2023-11-06
JP7410050B2 JP7410050B2 (ja) 2024-01-09

Family

ID=62063375

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020556943A Active JP7410050B2 (ja) 2018-04-25 2019-04-18 キノロンカルボン酸エステルの加水分解プロセス

Country Status (23)

Country Link
US (1) US11332444B2 (fr)
EP (1) EP3784656B1 (fr)
JP (1) JP7410050B2 (fr)
KR (1) KR20210005079A (fr)
CN (1) CN111989314B (fr)
AU (1) AU2019260015B2 (fr)
BR (1) BR112020021635A2 (fr)
CA (1) CA3098060A1 (fr)
CL (1) CL2020002735A1 (fr)
CO (1) CO2020013343A2 (fr)
CR (1) CR20200502A (fr)
DK (1) DK3784656T3 (fr)
DO (1) DOP2020000189A (fr)
ES (1) ES2956316T3 (fr)
IL (1) IL278175A (fr)
MX (1) MX2020011280A (fr)
PE (1) PE20201257A1 (fr)
PH (1) PH12020551750A1 (fr)
PT (1) PT3784656T (fr)
SG (1) SG11202010544TA (fr)
TW (1) TW202003470A (fr)
UY (1) UY38201A (fr)
WO (1) WO2019206798A1 (fr)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3420798A1 (de) 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-(3-aryl-l-piperazinyl)- sowie 7-(3-cyclohexyl-l-piperazinyl)-3-chinoloncarbonsaeuren
DE3702393A1 (de) 1987-01-28 1988-08-11 Bayer Ag 8-cyano-1-cyclopropyl-1,4-dihydro-4-oxo- 3-chinolincarbonsaeuren, verfahren zu ihrer herstellung und diese enthaltende antibakterielle mittel
CZ291251B6 (cs) 1996-02-23 2003-01-15 Bayer Aktiengesellschaft Popřípadě substituované 8-kyan-1-cyklopropyl-7-(2,8-diazabicyklo-[4,3,0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolinkarboxylové kyseliny a jejich deriváty, způsob jejich výroby, léčiva tyto látka obsahující a jejich pouľití
DE19652239A1 (de) 1996-12-16 1998-06-18 Bayer Ag Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen
CN1338455A (zh) * 2000-08-16 2002-03-06 大连绿源实业有限公司 新的喹诺酮羧酸的制备方法
DE10108750A1 (de) * 2001-02-23 2002-09-05 Bayer Ag Verbessertes Verfahren zur Herstellung von Fluorchinoloncarbonsäuren
DE10134719A1 (de) 2001-07-17 2003-02-06 Bayer Ag Pharmazeutische Zubereitungen enthaltend wirkstoffbeladene Ionentauscherharze
DE10224086A1 (de) 2002-05-31 2003-12-11 Bayer Ag Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker
US6900224B2 (en) * 2002-07-31 2005-05-31 The Procter & Gamble Company Antimicrobial quinolones, their compositions and uses
DE10312346A1 (de) 2003-03-20 2004-09-30 Bayer Healthcare Ag Kontrolliertes Freisetzungssystem
DE10337191A1 (de) 2003-08-13 2005-03-17 Bayer Healthcare Ag Neue Verwendung von Chinolon-Antibiotika
DE10351448A1 (de) 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
DE102005055385A1 (de) 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
CN105622632B (zh) * 2014-10-29 2018-06-29 浙江海森药业股份有限公司 一种喹诺酮类化合物及其制备方法

Similar Documents

Publication Publication Date Title
JP4584709B2 (ja) キノリン誘導体の製造工程
US7560557B2 (en) Process for the manufacture of quinoline derivatives
JP2986154B2 (ja) 2,4,5−トリフルオロ−6−アルキル安息香酸の製造方法
US6875869B2 (en) Process for the manufacture of quinoline derivatives
JPS61267573A (ja) キノロンカルボン酸誘導体
HU192398B (en) Process for producing derivatives of quinoline-carboxylic acids and pharmaceutical compositions of antibacterial activity containing them
CN106831723B (zh) 一种改进的德拉沙星的精制方法
JPWO2019206798A5 (fr)
JP7410050B2 (ja) キノロンカルボン酸エステルの加水分解プロセス
US6590101B2 (en) Process for the preparation of fluoroquinolonecarboxylic acids
RU2794892C2 (ru) Способ гидролиза эфиров хинолонкарбоновых кислот
JP2008105970A (ja) ジヒドロキノリン誘導体の製造方法及びその中間体
RU2020137809A (ru) Способ гидролиза эфиров хинолонкарбоновых кислот
CN105777631B (zh) 一种1-环丙基-4-氧代-7-溴-8-二氟甲氧基-1,4-二氢喹啉-3-羧酸乙酯的合成方法
JP2990903B2 (ja) 4−オキソキノリン−3−カルボン酸類の製造方法
JPH11292873A (ja) キノロンカルボン酸誘導体の製造方法およびその中間体
JPH0720940B2 (ja) キノリン誘導体の製造法
JPS61143363A (ja) キノロンカルボン酸誘導体の製造方法